TELA Bio, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

TELA Bio, Inc. reported Cash And Cash Equivalents At Carrying Value of $50.85 million for the year ending 2025.

  • TELA Bio, Inc. showed a decrease of -3.5% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from TELA Bio, Inc.'s annual report (Form 10-K), filed with the SEC on March 25, 2026.
  • XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 8 years of available data (2018 to 2025), TELA Bio, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 194.3%.
  • Historical annual values: Fiscal year 2025: $50.85 million | Fiscal year 2024: $52.67 million | Fiscal year 2023: $46.73 million | Fiscal year 2022: $42.02 million | Fiscal year 2021: $43.93 million | Fiscal year 2020: $74.39 million | Fiscal year 2019: $45.30 million | Fiscal year 2018: $17.28 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: